Skip to content

Find our latest news, stories and insights

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Catch up on the latest press releases and download media assets here

  1. Home/
  2. News/
  3. Innovation/
  4. Meet 3 men who’ve been on the front lines of HIV treatments for decades
Left to right: Joss J. De Wet, M.D., Johnson & Johnson's Brian Woodfall, M.D., and artist Tiko Kerr
Left to right: Joss J. De Wet, M.D., Johnson & Johnson’s Brian Woodfall, M.D., and artist Tiko Kerr Andy Meyers at M3 Creative

Meet 3 men who’ve been on the front lines of HIV treatments for decades

Johnson & Johnson’s Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That’s where he met Tiko Kerr, who became one of the first patients to take the company’s HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.

Left to right: Joss J. De Wet, M.D., Johnson & Johnson’s Brian Woodfall, M.D., and artist Tiko Kerr Andy Meyers at M3 Creative
hqdefault.jpg

We’re committed to helping lead the fight against HIV/AIDS

Read about the many ways Johnson & Johnson is working to #makeHIVhistory.

More from Johnson & Johnson

Moving toward a more personalized approach to treating depression

The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.

“Our goal is a solution for every bladder cancer patient”

Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.

Is this the end of one-size-fits-all treatments for depression?

Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.